HKD5.56
2.39%
Hong Kong, Apr 17, 10:08 am CET
ISIN
HK1093012172
Symbol
1093
Index
Sector
Industry

CSPC Pharmaceutical Group Limited Stock price

HKD5.56
+0.74 15.35% 1M
-0.52 8.55% 6M
+0.78 16.32% YTD
-0.25 4.30% 1Y
-2.95 34.67% 3Y
-2.98 34.91% 5Y
+1.40 33.61% 10Y
Hong Kong, Closing price Thu, Apr 17 2025
+0.13 2.39%
ISIN
HK1093012172
Symbol
1093
Index
Sector
Industry

Key metrics

Market capitalization HKD63.98b
Enterprise Value HKD57.62b
P/E (TTM) P/E ratio 13.91
EV/Sales (TTM) EV/Sales 1.83
P/S ratio (TTM) P/S ratio 2.03
P/B ratio (TTM) P/B ratio 1.76
Dividend yield 5.40%
Last dividend (FY23) HKD0.30
Revenue growth (TTM) Revenue growth -9.60%
Revenue (TTM) Revenue HKD31.45b
EBIT (operating result TTM) EBIT HKD5.80b
EPS (TTM) EPS HKD0.40
P/E forward 11.72
P/S forward 1.96
EV/Sales forward 1.76
Show more

Is CSPC Pharmaceutical Group Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

CSPC Pharmaceutical Group Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

17x Buy
63%
9x Hold
33%
1x Sell
4%

Analyst Opinions

27 Analysts have issued a CSPC Pharmaceutical Group Limited forecast:

Buy
63%
Hold
33%
Sell
4%

Financial data from CSPC Pharmaceutical Group Limited

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
31,450 31,450
10% 10%
100%
- Direct Costs 9,444 9,444
8% 8%
30%
22,006 22,006
10% 10%
70%
- Selling and Administrative Expenses 9,131 9,131
11% 11%
29%
- Research and Development Expense 5,628 5,628
5% 5%
18%
7,248 7,248
19% 19%
23%
- Depreciation and Amortization 1,449 1,449
18% 18%
5%
EBIT (Operating Income) EBIT 5,799 5,799
25% 25%
18%
Net Profit 4,692 4,692
28% 28%
15%

In millions HKD.

Don't miss a Thing! We will send you all news about CSPC Pharmaceutical Group Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

CSPC Pharmaceutical Group Ltd. is an investment holding company, which is engaged in the manufacturing and selling of pharmaceutical products. It operates through the following business segments: Finished Drugs, Antibiotics, Vitamin C, Caffeine and Others. The company was founded on August 21, 1997 and is headquartered in Hong Kong.

Head office Hong Kong
CEO Cui Zhang
Employees 21,400
Founded 1997
Website www.cspc.com.hk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today